- Nephros has the only hemodiafiltration system approved by the FDA for use in the U.S.
- DaVita announced on May 13, 2014, that it is delivering Nephros' hemodiafiltration therapy to select patients as part of a six-month trial program.
- Dialysis treatment in the U.S. has been exclusively done by hemodialysis, but several studies and routine use of hemodiafiltration therapy in Europe indicate better patient outcomes.
- DaVita and Fresenius control most of the U.S. dialysis market. In Europe, over 50% of Fresenius patients already receive hemodiafiltration treatment. However, their system is not FDA approved.